Clinical Trials
3 trialsNCT03549000 2024-12-13
A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.
Novartis
Phase 1 Terminated
NCT00014131 2023-10-04
Vaccine Therapy in Treating Patients With Kidney Cancer
Lisata Therapeutics, Inc.
Phase 1 Terminated
NCT01413087 2019-11-01
LAPC-BC-819
Anchiano Therapeutics Israel Ltd.
Phase 2 Terminated